Comparative Effectiveness of Second-Line Antihyperglycemic Agents for Cardiovascular Outcomes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of the American College of Cardiology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Comparative Effectiveness of Second-Line Antihyperglycemic Agents for Cardiovascular Outcomes: A Multinational, Federated Analysis of LEGEND-T2DM
J Am Coll Cardiol 2024 Sep 03;84(10)904-917, R Khera, A Aminorroaya, LS Dhingra, PM Thangaraj, A Pedroso Camargos, F Bu, X Ding, A Nishimura, TV Anand, F Arshad, C Blacketer, Y Chai, S Chattopadhyay, M Cook, DA Dorr, T Duarte-Salles, SL DuVall, T Falconer, TE French, EE Hanchrow, G Kaur, WCY Lau, J Li, K Li, Y Liu, Y Lu, KKC Man, ME Matheny, N Mathioudakis, JA McLeggon, MF McLemore, E Minty, DR Morales, P Nagy, A Ostropolets, A Pistillo, TP Phan, N Pratt, C Reyes, L Richter, JS Ross, E Ruan, SL Seager, KR Simon, B Viernes, J Yang, C Yin, SC You, JJ Zhou, PB Ryan, MJ Schuemie, HM Krumholz, G Hripcsak, MA SuchardFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.